Arbutus Biopharma Corporation
NasdaqGS:ABUS
Sector
Location
Market Cap
USD 651.78 M
Share Price
USD 3.40
Avg Daily Volume
764,883
Change (1 day)
0.00%
Change (1 year)
-5.56%
Change (YTD)
3.98%
Arbutus Biopharma Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024: USD -71.57 M
Arbutus Biopharma Corporation Operating Cash Flow is USD -71.57 M for the Trailing 12 Months (TTM) ending June 30, 2024, a -13.29% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Arbutus Biopharma Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -82.54 M.
-
Arbutus Biopharma Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -59.08 M, a -3.27% change year over year.
-
Arbutus Biopharma Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2020 was USD -61.08 M.
StockViz
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Pfizer Inc.
USD 24.58
PFE
+0.35
1.44%
Gilead Sciences, Inc.
USD 119.41
GILD
+9.13
8.28%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
Vertex Pharmaceuticals Incorporated
USD 366.54
VRTX
-9.09
-2.42%
Bristol-Myers Squibb Company
USD 45.95
BMY
+0.59
1.30%
Chugai Pharmaceutical Co., Ltd.
USD 41.22
4519.T
-9.07
-18.03%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Pfizer Inc.
USD 24.58
PFE
+0.35
1.44%
Gilead Sciences, Inc.
USD 119.41
GILD
+9.13
8.28%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
Vertex Pharmaceuticals Incorporated
USD 366.54
VRTX
-9.09
-2.42%
Bristol-Myers Squibb Company
USD 45.95
BMY
+0.59
1.30%
Chugai Pharmaceutical Co., Ltd.
USD 41.22
4519.T
-9.07
-18.03%